相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。What is the true incidence of COVID-19 in patients with rheumatic diseases?
Ennio Giulio Favalli et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Hussin A. Rothan et al.
JOURNAL OF AUTOIMMUNITY (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Essentials for Radiologists on COVID-19: An Update-Radiology Scientific Expert Panel
Jeffrey P. Kanne et al.
RADIOLOGY (2020)
Time Course of Lung Changes a Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19 )
Feng Pan et al.
RADIOLOGY (2020)
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
Sara Monti et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Tocilizumab treatment in COVID-19: A single center experience
Pan Luo et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Tao Chen et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Real estimates of mortality following COVID-19 infection
David Baud et al.
LANCET INFECTIOUS DISEASES (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
Irani Thevarajan et al.
NATURE MEDICINE (2020)
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Mayla Gabriela Silva Borba et al.
JAMA NETWORK OPEN (2020)
Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019
Stephan D. Fihn et al.
JAMA NETWORK OPEN (2020)
Gastrointestinal Manifestations of Rheumatological Diseases
Paul T. Kroner et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Fatigue, Sleep, and Autoimmune and Related Disorders
Mark R. Zielinski et al.
FRONTIERS IN IMMUNOLOGY (2019)
Therapeutic Mechanisms of Glucocorticoids
Jolien Vandewalle et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
Tocilizumab (Actemra)
Martin Sheppard et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
New insights into the immunopathogenesis of systemic lupus erythematosus
George C. Tsokos et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Management of interstitial lung disease associated with connective tissue disease
Stephen C. Mathai et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Management of interstitial lung disease associated with connective tissue disease
Stephen C. Mathai et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Advances in understanding the pathogenesis of primary Sjogren's syndrome
Gaetane Nocturne et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
分享论文
